|
⚲
|
| Aveo Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001325879 |
| Sale | 2009-03-18 ($60.0 M Offered, $30.0 M Sold) |
| Fund | |
| Phone | 6172995000 |
| Address | 75 Sidney Street Cambridge, 02139 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Tuan Hangoc | |
| Ken Bate | |
| Ronald Depinho | |
| Kenneth Weg | |
| Robert Higgins | |
| Joseph Vittiglio | |
| Anthony Evnin | |
| Douglas Cole | |
| Nicholas Galakatos | |
| Raju Kucherlapati | |
| David Johnson | |
| Russell Hirsch |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
VI Fund I, a series of ODX Investments, LP
✚
|
0.0 | |
|
Durango Gold Corp.
✚
|
0.0 | |
|
Dura Software, Inc.
✚
|
0.0 | |
|
Durham Developer, LLC
✚
|
0.0 | |
|
Durhamite Holdings LLC
✚
|
0.0 | |
|
Duro Ventures, LP - C3
✚
|
0.0 | |
|
Du Roy de Blicquy Corentin
✚
|
0.0 | |
|
Dust, a Series of Vauban Platform LP
✚
|
0.0 | |
|
Dutchess Capital Growth Fund LP
✚
|
0.0 | |
|
VI Fund I, a series of Heron Rock AL Access Funds, LP
✚
|
0.0 |